يعرض 1 - 20 نتائج من 652 نتيجة بحث عن '"Leon, Dario A."', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Report
  2. 2
    Report
  3. 3
    Report
  4. 4
    Report
  5. 5
    Report
  6. 6
    Report
  7. 7
    Report
  8. 8
    Report
  9. 9
    Report
  10. 10
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المصدر: Biomedica; Vol. 44 No. 2 (2024); 191-206 ; Biomédica; Vol. 44 Núm. 2 (2024); 191-206 ; 2590-7379 ; 0120-4157

    وصف الملف: application/pdf

    Relation: https://revistabiomedica.org/index.php/biomedica/article/view/6742/5481; Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. La clasificación de la OMS de 2007 de tumores del sistema nervioso central. Acta Neuropathol. 2007;114:97-109. http://doi.org/10.1007/s00401-007-0243-4; WHO. Media Centre. The top 10 causes of death. 2012. Consulted: June 1th, 2017. Available: http://www.who.int/mediacentre/factsheets/fs310/en/; Piñeros M, Sierra MS, Izarzugaza MI, Forman D. Epidemiología descriptiva de los cánceres de cerebro y del sistema nervioso central en Centro y Sudamérica. Cáncer Epidemiol. 2016;44:S141–9. https://doi.org/10.1016/j.canep.2016.04.007; Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. Clasificación de tumores del sistema nervioso central de 2016 de la organización mundial de la salud: resumen. Acta Neuropathol. 2016;131:803-20. https://doi.org/10.1007/s00401-016-1545-1; The International Agency for Research on Cancer (IARC). Global Cancer Observatory. Accessed: July 18, 2014. Available at: https://gco.iarc.fr/en; Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136. https://doi.org/10.1002/ijc.29210; Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96. https://doi.org/10.1056/nejmoa043330; Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol. 2009;10:459-66. https://doi.org/10.1016/S1470-2045(09)70025-7; Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108:11–27. https://doi.org/10.1007/s11060-011-0793-0; Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, et al. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro Oncol. 2011;13:1370–8. https://doi.org/10.1093/neuonc/nor120; Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, et al. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in Research studies in the United States. Clin Cancer Res. 2010;16:2443-9. https://doi.org/10.1158/1078-0432.CCR-09-3106; Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012;14(Suppl.5):1-49. https://doi.org/10.1093/neuonc/nos218; Alentorn A, Duran-Peña A, Pingle SC, Piccioni DE, Idbaih A, Kesari S. Molecular profiling of gliomas: potential therapeutic implications. Expert Rev Anticancer Ther. 2015;15:955-62. https://doi.org/10.1586/14737140.2015.1062368; Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, et al. Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol. 2009;11:242-9. https://doi.org/10.1215/15228517-2009-002; Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, et al. Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr. 2010;92:1145-50. https://doi.org/10.3945/ajcn.2010.29876; Wigertz A, Lonn S, Hall P, Feychting M. Non-participant characteristics and the association between socioeconomic factors and brain tumour risk. J Epidemiol Community Health. 2010;64:736-43. https://doi.org/10.1136/jech.2008.085845; Baglietto L, Giles GG, English DR, Karahalios A, Hopper JL, Severi G. Alcohol consumption and risk of glioblastoma; evidence from the Melbourne collaborative cohort study. Int J Cancer. 2011;128:1929-34. https://doi.org/10.1002/ijc.25770; Cardis E, Armstrong BK, Bowman JD, Giles GG, Hours M, Krewski D, et al. Risk of brain tumours in relation to estimated RF dose from mobile phones: Results from five Interphone countries. Occup Environ Med. 2011;68:631-40. https://doi.org/10.1136/oemed-2011-100155; Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Family and personal medical history and risk of meningioma. J Neurosurg. 2011;115:1072–7. https://doi.org/10.3171/2011.6.JNS11129; Claus EB, Calvocoressi L, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M. Dental x-rays and risk of meningioma. Cancer. 2012;118:4530–7. https://doi.org/10.1002/cncr.26625; Scheurer ME, Amirian ES, Davlin SL, Rice T, Wrensch M, Bondy ML. Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer. 2011;129:2290-6. https://doi.org/10.1002/ijc.25883; Yiin JH, Brain Cancer Collaborative Study Group, Ruder AM, Stewart PA, Waters MA, Carreón T, et al. The upper midwest health study: A case–control study of pesticide applicators and risk of glioma. Environ Health. 2012;11. https://doi.org/10.1186/1476-069x-11-39; Dertinger SD, Camphausen K, MacGregor JT, Bishop ME, Torous DK, Avlasevich S, et al. Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environ Mol Mutagen. 2004;44:427-35. https://doi.org/10.1002/em.20075; Dertinger SD, Miller RK, Brewer K, Smudzin T, Torous DK, Roberts DJ, et al. Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat Res Genet Toxicol Environ Mutagen. 2007;626:111-9. https://doi.org/10.1016/j.mrgentox.2006.09.003; Dertinger SD, Torous DK, Hayashi M, MacGregor JT. Flow cytometric scoring of micronucleated erythrocytes: An efficient platform for assessing in vivo cytogenetic damage. Mutagenesis. 2011;26:139-45. https://doi.org/10.1093/mutage/geq055; Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res Genet Toxicol Environ Mutagen. 2003;534:65-75. https://doi.org/10.1016/s1383-5718(02)00249-8; Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc. 2007;2:1084-104. https://doi.org/10.1038/nprot.2007.77; Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 1974;251:156-8. https://doi.org/10.1038/251156a0; Collett D. Modelling survival data in medical research. 3rd ed. Boca Raton, London, New York: CRC Press; 2015. https://doi.org/10.1201/b18041; Kleinbaum, D, Kupper L, Nizam A, Rosenberg, E. Applied regression analysis and other multivariable methods. 5th. ed. Canada: Nelson Education; 2013.; Burbine A, Fryer D, Sturtevant J. Akaike information criterion to select well-fit resist models. In: Sturtevant JL, Capodieci L, editors. SPIE Proceedings; San José, California; 2015. https://doi.org/10.1117/12.2085770; WHO. Población (OMS). 2015. Accessed. July 17, 2017. Available at: http://www.who.int/ageing/publications/world-report-2015/es/; Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A, et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol. 2007;114:97-109.; Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803-20. https://doi.org/10.1007/s00401-016-1545-1; Marumoto T, Saya H. Molecular biology of glioma. Adv Exp Med Biol. 2012;746:2-11. https://doi.org/10.1007/978-1-4614-3146-6_1; WHO. Obesidad y sobrepeso. 2004. Accesssed: Febrary 18, 2024. Available at: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight; Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25:867-90. https://doi.org/10.1016/j.ncl.2007.07.002; Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012;48:1532-42. https://doi.org/10.1016/j.ejca.2011.12.013; Yang P, Wang Y, Peng X, You G, Zhang W, Yan W, et al. Management and survival rates in patients with glioma in China (2004-2010): A retrospective study from a single-institution. J Neurooncol. 2013;113:259-66. https://doi.org/10.1007/s11060-013-1103-9; Instituto Nacional de Cancerología. Anuario Estadístico 2008. Accessed: February 6, 2017. Available at: https://www.cancer.gov.co/conozca-sobre-cancer-1/publicaciones/anuarioestadistico-2008; Casartelli G, Dorcaratto A, Ravetti JL, Sola S, Vitali A, Merlo DF, et al. Survival of high grade glioma patients depends on their age at diagnosis. Cancer Biol Ther. 2009;8:1719–21. https://doi.org/10.4161/cbt.8.18.9209; Cabaniols C, Giorgi R, Chinot O, Ferahta N, Spinelli V, Alla P, et al. Links between private habits, psychological stress and brain cancer: a case–control pilot study in France. J Neurooncol. 2011;103:307-16. https://doi.org/10.1007/s11060-010-0388-1; Plascak JJ, Fisher JL. Area-based socioeconomic position and adult glioma: A hierarchical analysis of surveillance epidemiology and end results data. PLoS One. 2013;8:e60910. https://doi.org/10.1371/journal.pone.0060910; Mukerji N, Rodrigues D, Hendry G, Dunlop PRC, Warburton F, Kane PJ. Treating high grade gliomas in the elderly: the end of ageism? J Neurooncol. 2008;86:329-36. https://doi.org/10.1007/s11060-007-9476-2; View of neuropsychological characteristics of patients with glioma treated in the Institute of cancer of Medellín, Colombia. Incompleto ¿Año, volume, páginas? Actaneurologica.com. Consulted: February 18, 2024. Avalaible: https://www.actaneurologica.com/index.php/anc/article/view/1619/1359; Hardell L, Carlberg M, Hansson Mild K. Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma. Pathophysiology. 2013;20:85-110. https://doi.org/10.1016/j.pathophys.2012.11.001; Olar A, Sulman EP. Molecular markers in low-grade glioma-toward tumor reclassification. Semin Radiat Oncol. 2015;25:155-63. https://doi.org/10.1016/j.semradonc.2015.02.006; Lu J, Cowperthwaite MC, Burnett MG, Shpak M. Molecular predictors of long-term survival in glioblastoma multiforme patients. PLoS One. 2016;11:e0154313. http://doi.org/10.1371/journal.pone.0154313; Chang P, Li Y, Li D. Micronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk. Carcinogenesis. 2011;32:210-5. https://doi.org/10.1093/carcin/bgq247; Minniti G, Enrici RM. Radiation therapy for older adults with glioblastoma: Radical treatment, palliative treatment, or no treatment at all? J Neurooncol. 2014;120:225-33. https://doi.org/10.1007/s11060-014-1566-3; Neta G, Stewart PA, Rajaraman P, Hein MJ, Waters MA, Purdue MP, et al. Occupational exposure to chlorinated solvents and risks of glioma and meningioma in adults. Occup Environ Med. 2012;69:793-801. https://doi.org/10.1136/oemed-2012-100742; Lim YC, Roberts TL, Day BW, Harding A, Kozlov S, Kijas AW, et al. A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells. Mol Cancer Ther. 2012;11:1863-72. https://doi.org/10.1158/1535-7163.MCT-11-1044; https://revistabiomedica.org/index.php/biomedica/article/view/6742

  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Report
  19. 19
  20. 20
    Academic Journal